200 related articles for article (PubMed ID: 15887119)
1. Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance.
Ibdah JA; Perlegas P; Zhao Y; Angdisen J; Borgerink H; Shadoan MK; Wagner JD; Matern D; Rinaldo P; Cline JM
Gastroenterology; 2005 May; 128(5):1381-90. PubMed ID: 15887119
[TBL] [Abstract][Full Text] [Related]
2. Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect.
Rector RS; Morris EM; Ridenhour S; Meers GM; Hsu FF; Turk J; Ibdah JA
Hepatology; 2013 Jun; 57(6):2213-23. PubMed ID: 23359250
[TBL] [Abstract][Full Text] [Related]
3. Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death.
Ibdah JA; Paul H; Zhao Y; Binford S; Salleng K; Cline M; Matern D; Bennett MJ; Rinaldo P; Strauss AW
J Clin Invest; 2001 Jun; 107(11):1403-9. PubMed ID: 11390422
[TBL] [Abstract][Full Text] [Related]
4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mitochondrial trifunctional protein modulates nonalcoholic fatty liver disease in mice.
Nassir F; Arndt JJ; Johnson SA; Ibdah JA
J Lipid Res; 2018 Jun; 59(6):967-973. PubMed ID: 29581157
[TBL] [Abstract][Full Text] [Related]
6. Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
Li T; Feng R; Zhao C; Wang Y; Wang J; Liu S; Cao J; Wang H; Wang T; Guo Y; Lu Z
Antioxid Redox Signal; 2017 Apr; 26(11):598-609. PubMed ID: 27565538
[TBL] [Abstract][Full Text] [Related]
7. Post-mortem analysis for two prevalent beta-oxidation mutations in sudden infant death.
Yang Z; Lantz PE; Ibdah JA
Pediatr Int; 2007 Dec; 49(6):883-7. PubMed ID: 18045290
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
Kathirvel E; Morgan K; French SW; Morgan TR
Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
[TBL] [Abstract][Full Text] [Related]
9. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.
Li Z; Yang S; Lin H; Huang J; Watkins PA; Moser AB; Desimone C; Song XY; Diehl AM
Hepatology; 2003 Feb; 37(2):343-50. PubMed ID: 12540784
[TBL] [Abstract][Full Text] [Related]
10. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
11. Genipin ameliorates age-related insulin resistance through inhibiting hepatic oxidative stress and mitochondrial dysfunction.
Guan L; Feng H; Gong D; Zhao X; Cai L; Wu Q; Yuan B; Yang M; Zhao J; Zou Y
Exp Gerontol; 2013 Dec; 48(12):1387-94. PubMed ID: 24041487
[TBL] [Abstract][Full Text] [Related]
12. Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice.
Gruben N; Aparicio Vergara M; Kloosterhuis NJ; van der Molen H; Stoelwinder S; Youssef S; de Bruin A; Delsing DJ; Kuivenhoven JA; van de Sluis B; Hofker MH; Koonen DP
PLoS One; 2014; 9(4):e96345. PubMed ID: 24781986
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease.
Kathirvel E; Morgan K; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):973-83. PubMed ID: 19307976
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption.
Khaleel EF; Abdel-Aleem GA; Mostafa DG
Can J Physiol Pharmacol; 2018 Feb; 96(2):145-157. PubMed ID: 28777914
[TBL] [Abstract][Full Text] [Related]
15. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.
Shindo N; Fujisawa T; Sugimoto K; Nojima K; Oze-Fukai A; Yoshikawa Y; Wang X; Yasuda O; Ikegami H; Rakugi H
J Hepatol; 2010 Jun; 52(6):903-12. PubMed ID: 20392512
[TBL] [Abstract][Full Text] [Related]
16. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
17. Notch1 deficiency decreases hepatic lipid accumulation by induction of fatty acid oxidation.
Song NJ; Yun UJ; Yang S; Wu C; Seo CR; Gwon AR; Baik SH; Choi Y; Choi BY; Bahn G; Kim S; Kwon SM; Park JS; Baek SH; Park TJ; Yoon K; Kim BJ; Mattson MP; Lee SJ; Jo DG; Park KW
Sci Rep; 2016 Jan; 6():19377. PubMed ID: 26786165
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of sleep deprivation-induced hepatic steatosis and insulin resistance in mice.
Shigiyama F; Kumashiro N; Tsuneoka Y; Igarashi H; Yoshikawa F; Kakehi S; Funato H; Hirose T
Am J Physiol Endocrinol Metab; 2018 Nov; 315(5):E848-E858. PubMed ID: 29989853
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
20. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
